About Us
We harness the power of our proprietary metagenomics platform to create curative genetic medicines for patients
Our Origins
Our founders recognized the power that naturally evolved microbial systems could have in revolutionizing access to enhanced genome editing technologies to create potentially highly efficacious and curative genetic medicines
At Metagenomi, we believe genome editing tools with capabilities that go beyond the current technology landscape will be required in order to treat the vast majority of patients. Our goal is to unlock the full potential of genome editing by developing tools with new capabilities using novel cellular machinery discovered from the natural environment.
Metagenomi was founded by pioneers in the field of metagenomics. They recognized the power that naturally evolved microbial systems could have in revolutionizing access to enhanced genome editing technologies to create potentially highly efficacious and curative genetic medicines. Our metagenomics discovery platform enables us to rapidly and effectively find and engineer highly active natural enzymes sourced from nature into genome editing tools that are highly specific, efficient, and have enhanced targetability.
As the genetic medicine field continues to rapidly evolve, our platform positions us to be at the forefront of unlocking the full potential of genome editing through the continuous discovery of new editing systems and the development of the next wave of genetic medicines for patients.
Our Values
Driven by innovation
We think outside the confines of what is 'known' or considered 'possible'. Our compounding sense of wonder and curiosity permeate the barriers of scientific discovery. We explore, question, and focus our efforts towards finding novel solutions to change the future of human health.
Dedicated to scientific rigor
Our dedication to building a data-driven and scientifically rigorous enterprise supports our exploration of the unknown. We chart new paths of scientific inquiry with integrity and agility, learning as we go and pivoting when required. The quality of our work is what sets us apart — a product of our tenacity and drive for excellence.
Championed by each other
A supportive, inclusive environment of belonging gives rise to groundbreaking solutions. We hold space for each other, championing the wins and rebounding from the setbacks, together. We work towards our shared goal of developing curative therapeutics and strive for a profound impact on patient lives.
Board of Directors
-
Brian C. Thomas, PhD
CEO & Founder
-
Jürgen Eckhardt, MD, MBA
Head of Leaps by Bayer at Bayer
-
Sebastian Bernales, PhD
General Partner of Humboldt Fund
-
Willard H. Dere, MD
Professor Emeritus, Internal Medicine, University of Utah
-
Jian Irish, PhD, MBA
President & COO
Partners
Select Investors
Help us define the future of genetic medicine
If you’re looking to do groundbreaking work with an inspiring and inclusive team, join us.